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Abstract
Aflatoxin B1 (AFB1) is one of the major risk factors for liver cancer globally. A recent study 
showed that sulforaphane (SF), a potent inducer of phase II enzymes that occurs naturally in 
widely consumed vegetables, effectively induces hepatic glutathione S-transferases (GSTs) and 
reduces levels of hepatic AFB1-DNA adducts in AFB1-exposed Sprague Dawley rats. The present 
study characterized the effects of SF pre-treatment on global gene expression in the livers of 
similarly treated male rats. Combined treatment with AFB1 and SF caused reprogramming of a 
network of genes involved in signal transduction and transcription. Changes in gene regulation 
were observable 4 h after AFB1 administration in SF-pretreated animals and may reflect 
regeneration of cells in the wake of AFB1-induced hepatotoxicity. At 24 h after AFB1 
administration, significant induction of genes that play roles in cellular lipid metabolism and 
acetyl-CoA biosynthesis was detected in SF-pretreated AFB1-dosed rats. Induction of this group 
of genes may indicate a metabolic shift toward glycolysis and fatty acid synthesis to generate and 
maintain pools of intermediate molecules required for tissue repair, cell growth and compensatory 
hepatic cell proliferation. Collectively, gene expression data from this study provide insights into 
molecular mechanisms underlying the protective effects of SF against AFB1 hepatotoxicity and 
hepatocarcinogenicity, in addition to the chemopreventive activity of this compound as a GST 
inducer.
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Introduction
Aflatoxin B1 (AFB1) is a known human carcinogen that significantly contributes to the 
burden of hepatocellular carcinoma (HCC) in many parts of the world, especially in areas 
with a warm and moist climate such as Asia and sub-Saharan Africa (Kensler et al., 2011). 
A critical mechanism responsible for the hepatotoxic and carcinogenic potential of AFB1 is 
based on the balance of its bioactivation and detoxification (Figure 1). Several lines of 
evidence indicate that variation in the extent of glutathione (GSH) conjugation of the 
ultimate carcinogen, AFB1-8,9-epoxide, by glutathione S-transferases (GSTs) is an 
important detoxification pathway. Treatment of rats with oltipraz and 3H-1,2-dithiole-3-
thione (D3T) leads to marked increases in the activity of liver GSTs, which resulted in 
reductions in both the extent of aflatoxin-DNA adduction and tumorigenesis (Kensler et al., 
1987). The inducible A5 subunit of alpha-class GSTs in the rat has been identified as the 
GST isozyme that is primarily responsible for the enhanced detoxification of the AFB1-8,9-
epoxide by chemopreventive agents (Hayes et al., 1998). Modulation of GST activity is only 
one mechanism by which exogenous agents can influence aflatoxin carcinogenesis. This 
paper probes additional pathways.
Sulforaphane (SF), a potent isothiocyanate derivative found in broccoli and other 
cruciferous vegetables (Fahey et al., 1997) has received attention as a chemopreventive 
agent due to its ability to activate the transcription factor Nrf2 and induce phase II 
detoxification enzymes, including the GSTs (Fimognari and Hrelia, 2007; Myzak and 
Dashwood, 2006; Thimmulappa et al., 2002). Recent evidence illustrates protective effects 
of SF against AFB1-induced hepatotoxicity in rats attributable to increased GST expression. 
Treatment of rats with SF hepatic total GST activity and a proportional reduction in the 
amounts of AFB1-N7-guanine (the principal DNA adduct of AFB1) formed in liver DNA 
(Fiala et al., 2011). Previous studies, however, have also identified additional 
chemopreventive mechanisms for SF that are independent of phase II enzyme induction. SF 
induces apoptosis in both in vitro (Carmela Fimognari et al., 2004; Karmakar et al., 2006) 
and in vivo models (Singh et al., 2004). SF-mediated cell cycle arrest has been reported in 
many previous studies, including induction of a dose-dependent growth arrest in prostate 
cancer cells by inhibiting the expression of cyclin D1 and DNA synthesis, along with a G1 
cell cycle block (Chiao et al., 2002) and induction of G2/M accumulation and pre-metaphase 
arrest in bovine aortic endothelial (BAE) cells (Jackson et al., 2007). SF also exerts anti-
inflammatory properties by inhibiting pro-inflammatory and pro-carcinogenic signaling 
factors such as IL-1β (Lin et al., 2008), COX-2 and TNF-α (Heiss et al., 2001). 
Understanding these phase II-independent pathways provides the rationale for the current 
project.
Cell regeneration and survival responses signal metabolic reprogramming that supports 
anabolic pathways required for tissue repair and growth (Ward and Thompson, 2012). The 
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Keap1-Nrf2 complex, which is activated by SF, has been demonstrated to influence 
intermediary metabolism (Hayes and Dinkova-Kostova, 2014). This study aimed to assess 
the extent to which anabolic pathways modulated by SF provide protective mechanisms 
against AFB1 toxicity in vivo. The results revealed prominent reprogramming of gene sets 
involved in lipid synthesis in SF-pretreated rats, suggesting that SF facilitates regeneration 
of hepatic cells damaged by AFB1.
Materials and methods
Chemicals
R,S-Sulforaphane (SF) was purchased from LKT Laboratories (St. Paul, MN). Aflatoxin B1 
(AFB1) was purchased from Sigma Chemical (St. Louis, MO). RNAlater, RNeasy Mini Kit, 
and One-Step QuantiTech SYBR Green RT-PCR were obtained from QIAGEN (Valencia, 
CA). One-Cycle Target Labeling and Control Reagents complete kit (P/N 900493) and 
GeneChip® Rat Genome 230 2.0 arrays (Rat 230 2.0) were obtained from Affymetrix, Inc. 
(Santa Clara, CA). R-Phycoerythrinstreptavidin (SAPE) was purchased from Molecular 
Probes (Eugene, OR) and biotinylated, anti-streptavidin goat antibody was purchased from 
Vector Laboratories (Burlingame, CA). Reagent grade goat IgG was purchased from Sigma-
Aldrich (St. Louis, MO). Nuclease-free water was obtained from Ambion (Austin, TX). 
DNA primers for real time RT-PCR were ordered from Integrated DNA Technologies 
(Coralville, IA). Unless otherwise noted, all other chemicals and reagents were of ACS 
grade or better.
Animals
Male Sprague Dawley rats (21 days old; Charles River, Wilmington, MA) were fed the 
AIN76A diet (TestDiet, Richmond, IN) for one week prior to the start of the experiment. 
They were housed individually in facilities maintained at standard relative humidity and 
temperature, and 12 h: 12 h light: dark conditions, with food and water available ad libitum. 
All procedures involving animals followed NIH guidelines and protocols approved by the 
Massachusetts Institute of Technology Committee on Animal Care.
Treatment Protocol
Treatment groups consisted of 12 male Sprague Dawley rats randomly assigned into four 
groups of three. Rats were gavaged with corn oil or with 0.7 mmol/kg SF dissolved in corn 
oil at 30, 32, and 34 days of age (Figure 2). A previously performed dose-response study in 
male rats revealed that 0.7 mmol/kg SF was optimal for GST induction (Fiala et al., 2011). 
Twenty-four h after the third dose, animals in each group were injected intraperitoneally 
with 25 µg AFB1 in DMSO. All animals were sacrificed at 4 h or 24 h after AFB1 
administration. This experimental protocol is schematically illustrated in Figure 2. Livers 
were collected and submerged in RNAlater for further gene expression profiling by 
microarray and for validating the microarray results by RT-PCR.
RNA isolation procedure
Total RNA was isolated from RNAlater-stabilized rat livers using QIAshredder 
homogenization and RNeasy® Mini Kit from QIAGEN (Valencia, CA). Total RNA was 
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isolated and purified by a procedure performed as described in QIAGEN’s RNeasy® Animal 
Tissues protocol. The isolation method included a DNase digestion step according to the 
manufacturer’s instructions. Concentration and purity of isolated total RNA were 
preliminarily verified by checking the absorbance at 260 nm and 280 nm using a DU 730 
UV/Vis spectrophotometer (Beckman Coulter, CA, USA). The integrity of total RNA was 
assessed qualitatively by gel analysis using RNA 6000 Nano chips on an Agilent 2001 
(Agilent technologies, Berlin, Germany). RNA samples were used for gene expression 
analysis by microarray and RT-PCR.
Microarray preparation procedure
All procedures were performed as described in detail in the Affymetrix GeneChip® 
Expression Analysis Technical Manual. Biotin-labeled cRNA samples for hybridization on 
GeneChip® Rat 230 2.0 arrays were prepared using the “One-Cycle Target Labeling and 
Control Reagents complete kit.” A set of poly-A controls supplied in the kit was used as a 
positive control to monitor the entire target labeling process. Total RNA (15 µg) was reverse 
transcribed using a T7-oligo(dT) Promoter Primer in the first-strand cDNA synthesis 
reaction. Following this step, the process of RNase H-mediated second-strand cDNA 
synthesis was performed. The double-stranded cDNA was purified according to the Sample 
Cleanup Module protocol supplied with the kit and served as a template in the subsequent in 
vitro transcription (IVT) reaction. The IVT reaction was performed in the presence of T7 
RNA Polymerase and a biotinylated nucleotide analog/ribonucleotide mix for 
complementary RNA (cRNA) amplification and biotin labeling. The biotinylated cRNA was 
spectrophotometrically quantified prior to purifification and fragmentation in buffer supplied 
with the Sample Cleanup Module. Subsequently, the purified fragmented cRNA samples 
were hybridized to GeneChip® Rat 230 2.0 arrays (Rat 230 2.0) for 16 h at 45 °C in an 
Affymetrix Hybridization Oven 640. The microarrays were washed and stained with 
streptavidin-phycoerythrin (SAPE) on an Affymetrix Fluidics Station 450. A signal 
amplification step was included according to the manufacturer’s instructions. Fluorescent 
images were read using an Affymetrix®GeneChip®Scanner 3000.
Microarray data analysis
Raw data image files (DAT) were converted into CEL files using the Affymetrix Microarray 
Suite (MAS) 5.0. Probe-level intensity measurements were normalized using the Robust 
Multi-Array Average (RMA) method (Irizarry et al. 2003). The normalized signal intensities 
for each gene were averaged across three independent biological replicates (three rats for 
each experimental time point group). Differential expression was calculated using Spotfire 
DecisionSite® (TIBCO Software Inc., Palo Alto, CA). A significant difference in the 
expression of genes in the livers between SF-pretreated, AFB1-exposed rats and the 
corresponding non-SF pretreated, AFB1-exposed rats time-matched control groups was 
defined as the point at which the average fold change was greater than ±1.5 and the P-value 
was less than 0.05 (t-test). Spotfire was also used for visualization purposes, hierarchical 
clustering, and for searching the genes among categories. The WEB-based GEne SeT 
AnaLysis Toolkit (WebGestalt), which is available at http://bioinfo.vanderbilt.edu/
webgestalt/, was used for statistical enrichment analyses of differentially expressed genes 
(Zhang et al., 2004, 2005). WebGestalt was used to analyze probe sets with ±1.5 fold or 
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greater differential expression (P< 0.05) in the livers between SF-pretreated, AFB1-exposed 
rats and the corresponding non-SF pretreated, AFB1-exposed rats time-matched control 
groups against all probe sets available on the GeneChip® Rat 230 2.0 array. Gene ontology 
categories were considered statistically enriched when the P-value was 0.01 or less. 
Cytoscape, an open source bioinformatics software platform, was used for analyzing the 
gene-encoded protein interactions that were statistically deregulated in this study (Cline et 
al., 2007). GenMapp (Gene Map Annotator and Pathway Profiler), the open source 
bioinformatics software that is available on www.GenMapp.org (Gladstone Institutes, 
University of California at San Francisco), was used to visualize gene expression data on 
maps representing biological pathways.
Quantitative real-time RT-PCR for microarray results validation
Six to ten genes from each experimental group under study were selected as targets for real-
time RT-PCR to validate the microarray results. All primer sets were designed using 
Primer3 (Rosen and Skaletsky, 2000), which is available at http://www-genome.wi.mit.edu/
cgibin/primer/primer3.cgi/. The specificity of each primer was checked by BLAST searches. 
The oligonucleotide sequences of forward and reverse primers used for microarray results 
validation by RT-PCR in experimental groups of animals that were sacrificed at 4 h and at 
24 h time points are shown in Tables 1 and 2, respectively. Reverse transcription and PCR 
were performed following the manufacturer’s instructions using One-Step QuantiTech 
SYBR Green RT-PCR. Reverse transcription and PCR amplification were performed on a 
DNA Engine Opticon Thermal Cycler (MJ research, Waltham, MA). Data were analyzed 
using Opticon Monitor Software Cycler (MJ research, Waltham, MA). The background 
fluorescence was subtracted using the global minimum function available in the software. A 
standard dilution of a control sample was used to generate the standard curve. Melting curve 
analysis was used for quality control and data from samples with outlier melting 
temperatures were not used. As an endogenous control, the mRNA level of the 
housekeeping enzyme GAPDH was used to normalize the mRNA level reported for each 
gene.
Statistical analysis
Gene expression changes are presented as the average fold change between SF-pretreated, 
AFB1-exposed rats and the corresponding non-SF pretreated, AFB1-exposed rats time-
matched control groups. Differences between various groups were determined using a two 
sample t-test, with statistical significance set at P<0.05.
Results
Gene expression analysis
The goal of this study was to compare the response of rat liver to aflatoxin alone, or 
aflatoxin in concert with SF. The transcriptional responses in the livers of AFB1-treated 
male rats induced by SF were investigated using a DNA microarray, an established tool to 
assess global gene expression changes. Groups of rats were pretreated with 0.7 mmol/kg SF 
by gavage at ages 30, 32, and 34 days, a dose previously shown to induce GSTs significantly 
and result in a substantial reduction of AFB1-N7-guanine adduct levels in the livers of male 
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rats (Fiala et al., 2011). Control animals received corn oil at a comparable volume. On day 
35, 25 µg of AFB1 was given to all animals by intraperitoneal injection. This dose has 
previously been utilized in a multi-dose regimen to induce liver tumor formation in male 
Fischer rats (Egner et al., 1995). Livers from three animals per time point (4 h and 24 h) 
after AFB1 dosing were collected to investigate the response to SF treatment at the 
transcriptional level. Liver RNA was isolated as described, and subjected to microarray 
hybridization with arrays that contained 31,100 probe sets representing over 28,000 well-
substantiated rat genes. Data were normalized using the Robust-Multi-Chip Average 
method. The deregulated genes were selected with a requirement of at least 1.5-fold change 
with respect to the mean intensity of the control groups. The numbers of genes are given 
both as probe sets and as non-redundant genes to account for the fact that one gene can be 
represented by several probe sets on the arrays. The number of probe sets and the 
corresponding numbers of up- and down-regulated genes obtained by these analyses are 
given in Table 3. At 4 h, 81 probe sets representing 78 non-redundant genes were 
significantly deregulated, with 53 genes up-regulated and 25 genes down-regulated. At 24 h, 
110 probe sets representing 97 non-redundant genes were shown to be significantly 
deregulated; 51 genes upregulated and 46 genes downregulated.
Microarray validation
Six to ten genes from each experimental group were selected as targets for real-time RT-
PCR to validate the microarray results. The mean fold-change of all samples from 
identically SF- and AFB1-treated animals versus time-matched AFB1-treated controls were 
compared between microarray and real-time RT-PCR results. As shown in Figure 3, the RT-
PCR analysis corroborated the microarray results. A regression coefficient (Rs) of 0.926 and 
an R2 of 0.857 between the fold changes obtained from the two techniques confirmed that 
the gene expression changes detected by microarray represented actual deregulations (Figure 
4).
Functional analysis
To identify the pathways affected by SF in livers of AFB1-treated rats at 4 h and 24 h, each 
significantly deregulated gene was categorized according to its best known biological 
function. All recent gene annotations and information were obtained from NetAffx 
(Affymetrix, Inc.), the National Center for Biotechnology Information (NCBI) and Spotfire. 
It should be noted that gene categorization is imperfect as some genes are representative of 
more than one category. Numbers of significantly deregulated non-redundant genes assigned 
to their biological function categories at 4 h and 24 h are shown in Figures 5 and 6, 
respectively. Data of Expressed Sequence Tags (ESTs) and genes whose biological 
functions are not known or could not be specified with reasonable certainty were excluded.
The results showed that most of the genes deregulated at 4 h are involved in “Transcription”, 
whereas most of those deregulated at 24 h are involved in “Lipid metabolism”. Among the 
several functional groups classified, however, only three gene ontology categories related to 
biological processes were relatively enriched in the 4 h group. Table 4 shows gene ontology 
enrichment observed in the 4 h animals. The most highly enriched category in this 
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experimental group was “Establishment and/or maintenance of cell polarity” (R=20; 
P=0.0045).
Cell polarity is an essential feature of many animal cells; during cell division, the mitotic 
spindle aligns to the axis of cell polarity to correct the positioning of daughter cells and 
ensure that the localized molecules are properly distributed to the daughter cells. Within this 
category, two genes were significantly up-regulated, namely Discs large homolog-1 (Dlgh1) 
and Protein kinase C, iota (PKCζ). These two genes also play a role in controlling cell 
growth and survival. Dlgh1 is a membrane-associated guanylate kinase that functions as a 
molecular scaffold for the organization of signal tranducers within cells. It plays a key role 
in the regulation of T cell function including activation of the mitogen-activated protein 
(MAP) kinase p38 (Round et al., 2007; Zanin-Zhorov et al., 2012). Cytokines and 
chemokines expressed by T cells have crucial roles in liver regeneration and tumor 
promotion (Grivennikov et al., 2010). The Dlgh1 protein can also function as a growth 
regulator through interaction with the carboxyl-end of the tumor suppressor adenomatous 
polyposis coli (APC) protein (Ishidate et al., 2000). PKCζ is a member of the atypical PKC 
group that is an important regulator of inflammatory and survival pathways. It acts as a 
positive regulator of NF-κB (Diaz-Meco and Moscat, 2012) which plays an important role 
in the innate immune response, inflammation and cell survival (Sun and Karin, 2008; Karin 
et al., 2002). The second highest enriched category was “Positive regulation of 
development” (R=9.7; P=0.0034) with the other enriched category being “Transcription, 
DNA-dependent” (R=2.5; P=0.0031). The list of deregulated genes in each enriched 
category in the 4 h experimental group is shown in Table 5.
Among several functional groups of genes classified in the 24 h group, there are eight gene 
ontology categories in biological processes that were shown to be relatively enriched (Table 
6).
The most enriched of these was “Acetyl-CoA biosynthesis” (R= 50; P=0.0007), which 
contained two up-regulated genes, ATP citrate lyase (Acly) and dihydrolipoamide S-
acetyltransferase (Dlat). The second most enriched category was “Iron ion homeostasis” 
(R=16.67; P=0.0059), which contained one highly up-regulated gene, Transferrin receptor 
(Tfrc), and one markedly down-regulated gene, Hepcidin antimicrobial peptide (Hamp). 
Both proteins play roles in cellular iron uptake and transport. The rest of the enriched 
categories in this experimental group were identified as “Cellular lipid metabolism”, “Lipid 
metabolism”, “Fatty acid metabolism”, “Organic acid metabolism”, “Carboxylic acid 
metabolism”, and “Lipid biosynthesis” (P=0.0068). As suggested by their names, these 
categories shared a similar list of genes (see Table 7). Eight molecules that play roles in 
glycolysis and lipid metabolism could be integrated into the network as shown in Figure 7.
Molecules that were involved in metabolism were mapped into the common metabolic 
pathways of glycolysis, the TCA cycle, fatty acid synthesis and fatty acid β-oxidation. The 
pathways were combined and formatted to illustrate graphically how SF affects biochemical 
networks in AFB1-treated rat liver cells (see Figure 8).
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Discussion
AFB1 is one of the major risk factors for development of liver cancer, especially when it is 
present in concert with hepatitis B infection (Groopman and Kensler, 2005). 
Epidemiological investigations in human populations reveal an association of increased 
incidence of HCC with increasing dietary contamination by AFB1 (Wild and Gong, 2010). 
As the fungal species that produces AFB1 is ubiquitous, reduction of AFB1 exposure from 
ingestion may be problematic and impractical in certain areas of the world. 
Chemoprevention, that is the use of natural or synthetic agents to retard, block, or reverse 
the carcinogenic process, is an attractive strategy to mitigate the impact of AFB1 toxicity in 
high risk populations.
We recently showed that SF is a potent inducer of hepatic GST activity and reduces the 
amount of AFB1-N7-guanine formed in liver DNA in both sexes of Sprague Dawley and 
Fischer rats (Fiala et al., 2011). Our current study was carried out in an effort to understand 
further the in vivo mechanisms underlying the chemo-preventive action of SF against AFB1-
induced liver cancer. Male animals were used because males are more sensitive to AFB1 
than females. Effects of SF on biological networks of rat livers following AFB1-DNA 
adduction were explored by using microarray and RT-PCR techniques at two different time 
points, 4 h and 24 h, after AFB1 administration.
In the group of rats sacrificed 4 h after AFB1 administration, deregulation of a set of genes 
involved in signal transduction, transcription, and positive regulation of development was 
observed. While only three rats were used to keep the experiment at a manageable level, 
good statistical results were obtained. The results showed that SF enhanced the expression 
of genes involved in cytokine responses in a manner that would be expected to “favor” cell 
survival and regeneration. The expression changes observed in these gene sets may reflect 
the activation of signal transduction pathways required for the reprogramming of metabolic 
pathways to support anabolic growth in hepatocytes in the wake of cellular damage caused 
by AFB1 exposure.
At 24 h after AFB1 administration, up-regulation of transferrin receptor (Tfrc) expression is 
interpreted as a sign of hepatocyte regeneration. Transferrin receptors are expressed 
ubiquitously on proliferating cells (Besançon et al., 1987; Galbraith and Galbraith, 1981) 
and the interaction between transferrin and its receptor plays a crucial role in cell growth 
(Besançon et al., 1987). In addition, a shift in the dynamics of metabolic pathway regulation 
appears to have occurred upon SF pretreatment of AFB1-dosed male rats; for example, an 
induction of genes that play roles in cellular lipid biosynthesis and acetyl-CoA biosynthesis 
was evident 24 h after the AFB1 was administered. The enhanced gene expression profiles in 
these rats could be a response aimed at generating and maintaining pools of intermediate 
molecules needed for anabolism (DeBerardinis et al., 2007; Molenaar et al., 2009).
Some of the gene expression changes observed in livers of SF-pretreated, AFB1-dosed rats 
are reminiscent of changes induced during aerobic glycolysis (i.e., in tissues displaying the 
Warburg effect). The Warburg effect is postulated as a metabolic shift in energy production 
from oxidative phosphorylation to glycolysis, even in the presence of oxygen (Garber, 2004; 
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Kim and Dang, 2006). In cancer cells, this metabolic switch allows the cell to maintain 
bioenergetics and a rigorous biosynthetic program during growth and proliferation (Jones 
and Thompson, 2009). Moreover, this metabolic switch toward glycolysis for energy 
production may favor cell growth in the tumor microenvironment (Gatenby and Gillies, 
2004). Normal proliferating cells, such as primary lymphocytes, reveal similar patterns to 
those seen in cancer cells in their reliance on aerobic glycolysis to meet their bioenergetic 
needs (DeBerardinis et al., 2008; Jones and Thompson, 2007). In the present study, we see 
similar adaptations that effect pathways of glycolysis, the TCA cycle, fatty acid synthesis 
and fatty acid β-oxidation as shown in Figure 8.
Increases of pyruvate kinase (Pklr), dihydrolipoamide S-acetyltransferase (Dlat; the E2 
component of the pyruvate dehydrogenase complex), and pyruvate dehydrogenase (Pdh) 
gene expression were observed in livers of male rats that received SF and were sacrificed 24 
h after AFB1 administration. Increased expression of these enzymes, taken together, favor 
uptake of pyruvate into mitochondria, where it is converted to acetyl-CoA and enters the 
tricarboxylic acid (TCA) cycle. The acetyl-CoA entering the TCA cycle condenses with 
oxaloacetate (OA) to form citrate and then, rather than continuing in the TCA cycle, the 
citrate thereby formed is shunted to the cytoplasm of growing cells, where ATP citrate lyase 
(ACLY) converts it to cytoplasmic acetyl-CoA, which is required for lipogenesis (Ballard 
and Hanson, 1967). Lipid synthesis is very important in proliferating cells as phospholipids 
are a major structural component of biological membranes; examples include 
glycerolphospholipids, sphingolipids, and galactolipids (Nelson and Cox, 2009). Thus, this 
pathway’s upregulation by SF may be an important metabolic strategy to supply extra-
mitochondrial acetyl-CoA for lipogenesis (Ballard and Hanson, 1967). The results of this 
study also show that malic enzyme (Me), the cytosolic version of malate dehydrogenase 
(Mdh), and ATP citrate lyase (Acly) were induced. In order to sustain lipogenesis, cells must 
have abundant citrate synthesis in mitochondria. Mitochondrial OA is consumed during 
citrate production, and its level must be restored after transport of citrate to the cytoplasm in 
advance of lipid biosynthesis. Cytosolic Mdh works in series with Me in a pathway shunt 
that helps maintain mitochondrial OA levels. In addition to providing cells with biosynthetic 
precursors, another important feature of this shunt is the trans-hydrogenation of NADH to 
NADPH by Me working in concert with Mdh. This series of reactions augments the 
available extra-mitochondrial NADPH needed to support lipogenesis (Ballard and Hanson, 
1967). It is also possible that the generated NADPH would facilitate aflatoxin dialdehyde 
reduction as part of a detoxification strategy (Kelly et al., 2002). Moreover, aflatoxin 
treatment may deregulate glutathione metabolism, and the NADPH produced by this shunt 
may be used to maintain thiol pool homeostasis (Pashkov et al., 2005). We also note that 
glucose-6-phosphate dehydrogenase (G6pd) was increased in expression, although this 
enhancement did not reach the threshold for statistical significance. This enzyme is the 
portal to the pentose phosphate pathway, another major source of NADPH to support 
reductive biosynthesis. These changes are consistent with Nfr2-regulated genes that have 
been identified in Nrf2-deficient mouse models (Kwak et al., 2003; Wu et al., 2011).
Up-regulation of sterol regulatory element binding protein-1 (Srebp-1) in this group of SF-
treated animals may also reflect active cellular membrane synthesis. SREBPs are a family of 
basic helix-loop-helix-leucine zipper transcription factors (Horton et al., 2002; Rawson, 
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2003) that play crucial roles in regulating lipid homeostasis in vertebrate cells (Horton et al., 
2002). At present, three isoforms of Srebps have been identified; Srebp-1a, Srebp-1c, and 
Srebp-2 (Hua et al., 1993; Miserez et al., 1997). Srebp-1a and Srebp-1c are produced from a 
single gene with the use of alternate promoter start sites, while Srebp-2 is produced from a 
separate gene (Yokoyama et al., 1993). All are believed to form a homodimer to bind to the 
sterol regulatory elements (SREs) (Yokoyama et al., 1993). The three isoforms have 
different functions in the regulation of lipid synthesis. Evidence from many previous in vivo 
studies suggests that Srebp-1c is more active in enhancing lipogenic enzyme gene 
expression, whereas Srebp-1a and Srebp-2 are more specific to cholesterogenic genes. As 
shown in Figure 7, in this study, key lipogenic enzymes that are Srebp-1 target genes were 
up-regulated; Fatty acid synthase (Fasn), Elongation of long chain fatty acids protein 6 
(Elovl6), Acly and Me (Horton et al., 2002; Kumadaki et al., 2008). FASN is a multi-
enzyme complex that plays a central role in fatty acid synthesis (Nelson and Cox, 2009). 
ELOVL6 exhibits fatty acyl-CoA elongase activity specific for long chain fatty acids and is 
important for tissue fatty acid composition (Kumadaki et al., 2008). ACLY, as mentioned 
above, plays an early biochemical role in de novo fatty acid biosynthesis. Thus, the increase 
of Srebp-1 expression observed in this study is consistent with a role for SF as an inducer of 
lipogenic enzymes in AFB1-teated animals.
In addition to lipid-generating enzyme genes, the results showed the induction of the thyroid 
hormone responsive protein (Thrsp) mRNA transcript. Thrsp expression is also driven by 
SREBP-1 (Azzout-Marniche et al., 2000; Martel et al., 2006). Lipogenesis in tissues that 
synthesize fatty acids for use as fuel, such as liver, adipose and lactating mammary gland, is 
often regulated by thyroid hormone (Brown et al., 1997). Induction of the THRSP protein is 
likely to have occurred because its protein level usually parallels that of its mRNA (Kinlaw 
et al., 1989). The study of Brown and coworkers (1997) revealed that THRSP protein 
participates in induction of lipogenic enzyme genes, Fasn, Acly and Me, and glycolytic 
enzyme genes, such as Pklr and the gluconeogenic gene for phosphoenolpyruvate 
carboxykinase (Pepck). The mRNA transcripts for all of these enzymes were elevated in this 
study, except Pepck. Although THRSP can up-regulate Pepck gene expression, SREBP-1 
has a negative role in Pepck transcription. It has been proposed that SREBP-1c is an 
intermediate in the action of insulin on Pepck gene transcription (Chakravarty et al., 2001). 
SREBP-1c markedly decreases the basal level of cytosolic Pepck mRNA in isolated 
hepatocytes by blocking the interaction of specific transcription factors involved in cAMP 
regulation of Pepck gene transcription with cAMPbinding protein (Chakravarty et al., 2001). 
This result is consistent with an in vivo study, where hepatic Pepck mRNA levels were 
suppressed by overexpression of Srebp-1a and -1c in the SREBP transgenic mice 
(Yamamoto et al., 2004). The down-regulation of Pepck observed in this study seems 
logical. Pepck is a gluconeogenic enzyme and its expression would be counter to 
expectations given our other observations indicating strong activation of glycolysis. 
Gluconeogenesis and glycolysis thus appear to be reciprocally regulated in this study, as 
expected.
In summary, the gene expression data presented herein provide a snapshot of the genetic 
network perturbed by SF treatment in AFB1-treated rats. The data suggest a SF-mediated 
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adaptive response of cells following AFB1-induced cell damage. The gene expression data 
provide new insights into the molecular environment that exists in damaged cells pre-treated 
with the cancer chemopreventive agent, SF. Studies of this nature may prove useful in 
continuing efforts to identify novel pathways that could be induced or suppressed in an 
effort to ameliorate the risk for liver cancer created by exposure to aflatoxin.
Acknowledgments
This work was supported by National Institutes of Health grants ES016313, P30-ES002109; P01 ES006052; P30 
ES003819; P30 CA006973. The authors thank Drs. Stephen Slocum and Daam Settachan for critically reading the 
manuscript.
Abbreviations
SF Sulforaphane
AFB1 Aflatoxin B1
GST Glutathione S-Transferase
References
Azzout-Marniche D, Bécard D, Guichard C, Foretz M, Ferré P, Foufelle F. Insulin effects on sterol 
regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. 
Biochem J. 2000; 350:389–393. [PubMed: 10947952] 
Ballard FJ, Hanson RW. The citrate cleavage pathway and lipogenesis in rat adipose tissue: 
replenishment of oxaloacetate. J Lipid Res. 1967; 8:73–79. [PubMed: 14564711] 
Besançon F, Silbermann F, Dron M, Tovey MG, Thang MN, Bourgeade MF. Relationship between 
inhibition of cell growth and of transferrin receptor expression by interferon (IFN) alpha: studies in 
IFN-sensitive and IFN-resistant Daudi cells. J Gen Virol. 1987; 68:2647–2654. [PubMed: 3668508] 
Brown SB, Maloney M, Kinlaw B. “Spot 14” protein functions at the pretranslational level in the 
regulation of hepatic metabolism by thyroid hormone and glucose. J Biol Chem. 1997; 272:2163–
2166. [PubMed: 8999918] 
Busby, WF.; Wogan, GN. Aflatoxins. In: Searle, CE., editor. Chemical carcinogens, ACS Monograph 
182. 1984. p. 945-1136.
Chakravarty K, Leahy P, Becard D, Hakimi P, Foretz M, Ferre P, Foufelle F, Hanson RW. Sterol 
regulatory element-binding protein-1c mimics the negative effect of insulin on 
phosphoenolpyruvate carboxykinase (GTP) gene transcription. J Biol Chem. 2001; 276:34816–
34823. [PubMed: 11443121] 
Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, Conaway CC. Sulforaphane and its 
metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol. 2002; 
20:631–636. [PubMed: 11836580] 
Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, 
Creech M, Gross B, Hanspers K, Isserlin R, Kelley R, Killcoyne S, Lotia S, Maere S, Morris J, Ono 
K, Pavlovic V, Pico AR, Vailaya A, Wang PL, Adler A, Conklin BR, Hood L, Kuiper M, Sander C, 
Schmulevich I, Schwikowski B, Warner GJ, Ideker T, Bader GD. Integration of biological networks 
and gene expression data using Cytoscape. Nat Protoc. 2007; 2:2366–2382. [PubMed: 17947979] 
DeBerardinis RJ, Julian JL, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic 
reprogramming fuels cell growth and proliferation. Cell Metab. 2008; 7:11–20. [PubMed: 
18177721] 
DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. Beyond 
aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the 
requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA. 2007; 104:19345–
19350. [PubMed: 18032601] 
Techapiesancharoenkij et al. Page 11
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2016 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Diaz-Meco MT, Moscat J. The atypical PKCs in inflammation: NF-κB and beyond. Immunol Rev. 
2012; 246:154–167. [PubMed: 22435553] 
Egner PA, Gange SJ, Dolan PM, Groopman JD, Muñoz A, Kensler TW. Levels of aflatoxin-albumin 
biomarkers in rat plasma are modulated by both long-term and transient interventions with 
oltipraz. Carcinogenesis. 1995; 16:1769–1773. [PubMed: 7634402] 
Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes 
that protect against chemical carcinogens. Proc Natl Acad Sci USA. 1997; 94:10367–10372. 
[PubMed: 9294217] 
Fiala JL, Egner PA, Wiriyachan N, Ruchirawat M, Kensler KH, Wogan GN, Groopman JD, Croy RG, 
Essigmann JM. Sulforaphane-mediated reduction of aflatoxin B1-N7-guanine in rat liver DNA: 
impacts of strain and sex. Toxicol Sci. 2011; 121:57–62. [PubMed: 21278056] 
Fimognari C, Hrelia P. Sulforaphane as a promising molecule for fighting cancer. Mutat Res. 2007; 
635:90–104. [PubMed: 17134937] 
Fimognari C, Nüsse M, Berti F, Iori R, Cantelli-Forti G, Hrelia P. Isothiocyanates as novel cytotoxic 
and cytostatic agents: molecular pathway on human transformed and non-transformed cells. 
Biochem Pharmacol. 2004; 68:1133–1138. [PubMed: 15313410] 
Galbraith RM, Galbraith GM. Expression of transferrin receptors on mitogen-stimulated human 
peripheral blood lymphocytes: relation to cellular activation and related metabolic events. 
Immunology. 1981; 44:703–710. [PubMed: 6172372] 
Garber K. Energy boost: the Warburg effect returns in a new theory of cancer. J Natl Cancer Inst. 
2004; 96:1805–1806. [PubMed: 15601632] 
Gatenby RA, Robert JG. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004; 4:891–
899. [PubMed: 15516961] 
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140:883–899. 
[PubMed: 20303878] 
Groopman JD, Kensler TW. Role of metabolism and viruses in aflatoxin-induced liver cancer. Toxicol 
Appl Pharmacol. 2005; 206:131–137. [PubMed: 15967201] 
Hayes JD, Judah DJ, McLellan LI, Kerr LA, Peacock SD, Neal GE. Ethoxyquin-induced resistance to 
aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-
transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide. 
Biochem J. 1991; 279:385–398. [PubMed: 1953636] 
Hayes JD, Pulford DJ, Ellis EM, McLeod R, James RF, Seidegard J, Mosialou E, Jernström B, Neal 
GE. Regulation of rat glutathione S-transferase A5 by cancer chemopreventive agents: 
mechanisms of inducible resistance to aflatoxin B1. Chem Biol Interact. 1998; 111–112:51–67.
Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox 
and intermediary metabolism. Trends Biochem Sci. 2014; 39:199–218. [PubMed: 24647116] 
Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhäuser C. Nuclear factor-{kappa}B is a molecular target 
for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 2001; 276:32008–
32015. [PubMed: 11410599] 
Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and 
fatty acid synthesis in the liver. J Clin Invest. 2002; 109:1125–1131. [PubMed: 11994399] 
Hua X, Yokoyama C, Wu J, Briggs MR, Brown MS, Goldstein JL, Wang X. SREBP-2, a second 
basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol 
regulatory element. 1993; 90:11603–11607.
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, 
normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 
2003; 4:249–264. [PubMed: 12925520] 
Ishidate T, Matsumine A, Toyoshima K, Akiyama T. The APC-hDLG complex negatively regulates 
cell cycle progression from the G0/G1 to S phase. Oncogene. 2000; 19:365–372. 2000. [PubMed: 
10656683] 
Jackson SJ, Singletary KW, Venema RC. Sulforaphane suppresses angiogenesis and disrupts 
endothelial mitotic progression and microtubule polymerization. Vascul Pharmacol. 2007; 46:77–
84. [PubMed: 16938492] 
Techapiesancharoenkij et al. Page 12
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2016 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes 
Dev. 2009; 23:537–548. [PubMed: 19270154] 
Jones RG, Thompson CB. Revving the Engine: Signal Transduction Fuels T Cell Activation. 
immunity. 2007; 27:173–178. [PubMed: 17723208] 
Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. 
Nat Rev Cancer. 2002; 2:301–310. 2002. [PubMed: 12001991] 
Karmakar S, Weinberg MS, Banik NL, Patel SJ, Ray SK. Activation of multiple molecular 
mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with 
sulforaphane. Neuroscience. 2006; 141:1265–1280. [PubMed: 16765523] 
Kelly VP, Sherratt PJ, Crouch DH, Hayes JD. Novel homodimeric and heterodimeric rat gamma-
hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of 
aldo-keto reductase 7 family proteins. Biochem J. 2002; 366(Pt 3):847–861. [PubMed: 12071861] 
Kensler TW, Roebuck BD, Wogan GN, Groopman JD. Aflatoxin: a 50-year odyssey of mechanistic 
and translational toxicology. Toxicol Sci. 2011; 120(Suppl 1):S28–S48. [PubMed: 20881231] 
Kensler TW, Egner PA, Dolan PM, Groopman JD, Roebuck BD. Mechanism of protection against 
aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and 
related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res. 1987; 47:4271–4277. [PubMed: 
2886217] 
Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 2006; 
66:8927–8930. [PubMed: 16982728] 
Kinlaw WB, Ling NC, Oppenheimer JH. Identification of rat S14 protein and comparison of its 
regulation with that of mRNA S14 employing synthetic peptide antisera. J Biol Chem. 1989; 
264:19779–19783. [PubMed: 2584193] 
Kumadaki S, Matsuzaka T, Kato T, Yahagi N, Yamamoto T, Okada S, Kobayashi K, Takahashi A, 
Yatoh S, Suzuki H, Yamada N, Shimano H. Mouse Elovl-6 promoter is an SREBP target. 
Biochem Biophys Res Commun. 2008; 368:261–266. [PubMed: 18226595] 
Kwak MK, Wakabayashi N, Itoh K, Motohashi H, Yamamoto M, Kensler TW. Modulation of gene 
expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. 
Identification of novel gene clusters for cell survival. J Biol Chem. 2003; 278:8135–8145. 
[PubMed: 12506115] 
Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN. Sulforaphane suppressed LPS-induced 
inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem 
Pharmacol. 2008; 76:967–973. [PubMed: 18755157] 
Liu YL, Roebuck BD, Yager JD, Groopman JD, Kensler TW. Protection by 5-(2-pyrazinyl)-4-
methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the rat. Toxicol 
Appl Pharmacol. 1988; 93:442–451. [PubMed: 3130679] 
Martel PM, Bingham CM, McGraw CJ, Baker CL, Morganelli PM, Meng ML, Armstrong JM, 
Moncur JT, Kinlaw WB. S14 protein in breast cancer cells: direct evidence of regulation by 
SREBP-1c, super induction with progestin, and effects on cell growth. Exp Cell Res. 2006; 
312:278–288. [PubMed: 16300755] 
Miserez AR, Cao G, Probst LC, Hobbs HH. Structure of the Human Gene Encoding Sterol Regulatory 
Element Binding Protein 2 (SREBF2). Genomics. 1997; 40:31–40. [PubMed: 9070916] 
Molenaar D, van Berlo R, de Ridder D, Teusink B. Shifts in growth strategies reflect tradeoffs in 
cellular economics. MolSyst Biol. 2009; 5:323.
Myzak, Melinda C, Roderick H, Dashwood. Chemoprotection by sulforaphane: keep one eye beyond 
Keap1. Cancer Lett. 2006; 233:208–218. [PubMed: 16520150] 
Nelson, DL.; Cox, MM. Lehninger Principles of Biochemistry. fifth ed.. New York: W.H. Freeman 
Publishers; 2009. 
Pashkov AN, Popov SS, Semenikhina AV, Rakhmanova TI. Glutathione system and activity of nadph-
generating enzymes in the liver of intact rats and animals with toxic hepatitis receiving melatonin. 
Bull Exp Biol Med. 2005; 139:565–568. [PubMed: 16224550] 
Rawson RB. The SREBP pathway - insights from insigs and insects. Nat Rev Mol Cell Biol. 2003; 
4:631–640. [PubMed: 12923525] 
Techapiesancharoenkij et al. Page 13
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2016 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Rosen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. 
Methods Mol Biol. 2000; 132:365–386. [PubMed: 10547847] 
Round JL, Humphries LA, Tomassian T, Mittelstadt P, Zhang M, Miceli MC. Scaffold protein Dlgh1 
coordinates alternative p38 kinase activation, directing T cell receptor signals toward NFAT but 
not NF-kappaB transcription factors. Nat Immunol. 2007; 8:154–161. [PubMed: 17187070] 
Singh AV, Xiao D, Lew KL, Dhir R, Singh SV. Sulforaphane induces caspasemediated apoptosis in 
cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. 
Carcinogenesis. 2004; 25:83–90. [PubMed: 14514658] 
Sun B, Karin M. NF-kappaB signaling, liver disease and hepatoprotective agents. Oncogene. 2008; 
27:6228–6244. [PubMed: 18931690] 
Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. Identification of Nrf2-
regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide 
microarray. Cancer Res. 2002; 62:5196–5203. [PubMed: 12234984] 
Ward PS1, Thompson CB. Signaling in control of cell growth and metabolism. Cold Spring Harb 
Perspect Biol. 2012; 4:a006783. [PubMed: 22687276] 
Wild CP, Gong YY. Mycotoxins and human disease: a largely ignored global health issue. 
Carcinogenesis. 2010; 31:71–82. [PubMed: 19875698] 
Wu KC, Cui JY, Klaassen CD. Beneficial role of Nrf2 in regulating NADPH generation and 
consumption. Toxicol Sci. 2011; 123:590–600. [PubMed: 21775727] 
Yamamoto T, Shimano H, Nakagawa Y, Ide T, Yahagi N, Matsuzaka T, Nakakuki M, Takahashi A, 
Suzuki H, Sone H, Toyoshima H, Sato R, Yamada N. SREBP-1 interacts with hepatocyte nuclear 
factor-4 alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes. J 
Biol Chem. 2004; 279:12027–12035. [PubMed: 14722127] 
Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS. SREBP-1, a 
basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density 
lipoprotein receptor gene. Cell. 1993; 75:187–197. [PubMed: 8402897] 
Zanin-Zhorov A, Lin J, Scher J, Kumari S, Blair D, Hippen KL, Blazar BR, Abramson SB, Lafaille JJ, 
Dustin ML. Scaffold protein Disc large homolog 1 is required for T-cell receptor-induced 
activation of regulatory T-cell function. Proc Natl Acad Sci USA. 2012; 109:1625–1630. 
[PubMed: 22307621] 
Zhang B, Schmoyer D, Kirov S, Snoddy J. GOTree Machine (GOTM): a webbased platform for 
interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics. 
2004; 5:16–16. [PubMed: 14975175] 
Zhang B, Kirov SA, Snoddy JR. WebGestalt: an integrated system for exploring gene sets in various 
biological contexts. Nucleic Acids Res. 2005; 33(Web Server issue):W741–W748. [PubMed: 
15980575] 
Techapiesancharoenkij et al. Page 14
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2016 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Highlights
• This study revealed sulforaphane (SF)-deregulated gene sets in aflatoxin B1 
(AFB1)-treated rat livers.
• SF redirects biochemical networks toward lipid biosynthesis in AFB1-dosed 
rats.
• SF enhanced gene sets that would be expected to favor cell repair and 
regeneration.
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Figure 1. 
Pathway of metabolic activation of aflatoxin B1 and disruption of the pathway by 
sulforaphane (SF). Aflatoxin is metabolized by cytochrome P450 (Cyp450) oxidases to the 
8,9-epoxide, which reacts with DNA to form DNA adducts with guanine residues. The 
guanine adducts are presumably the functional precursors to carcinogenesis and significant 
contributors to toxicity. SF induces glutathione transferases (GSTs) and epoxide hydrolases 
(EH) and downregulates certain Cyp450s. Each of these alterations in enzyme activities 
would affect the intracellular concentration of the epoxide, hence modulating the levels of 
DNA adducts.
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Figure 2. 
Experimental protocol. Effects of sulforaphane on transcriptional responses were evaluated 
in the livers of male Sprague-Dawley rats. ● Indicates start of AIN76A diet; ↓ Indicates 
gavage with sulforaphane or corn oil. Each group consisted of 3 animals.
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Figure 3. 
Validation of gene expression results from microarray by using RT-PCR. Each bar is the 
fold induction of the selected genes obtained by microarray (black bars) or RTPCR (gray 
bars).
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Figure 4. 
Correlation of fold changes obtained from microarray and RT-PCR analyses. The mean of 
fold change of all samples from identically SF and AFB1-treated animals versus time-
matched AFB1-treated controls analyzed by microarray and real-time RT-PCR were plotted.
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Figure 5. 
Numbers of significant deregulated genes observed at 4 h in SF and AFB1-treated animals 
compared to the time-matched AFB1-treated controls which were assigned to their 
biological function categories.
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Figure 6. 
Numbers of significant deregulated genes observed at 24 h in SF and AFB1-treated animals 
compared to the time-matched AFB1-treated controls which were assigned to their 
biological function categories.
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Figure 7. 
The molecular interactions among proteins encoded by the deregulated genes observed in 
the 24 h group.↑ Indicates upregulation of gene expression. ↓ Indicates downregulation of 
gene expression.
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Figure 8. 
SF-induced alteration of common metabolic pathway in liver of 24 h rats. ↑ Indicates up-
regulation of gene expression. ↓ Indicates down-regulation of gene expression. G, glucose; 
PEP, phosphoenolpyruvate; PKLR, pyruvate kinase; P, pyruvate; DLAT, E2 component of 
the pyruvate dehydrogenase complex; PDH, pyruvate dehydrogenase; AcCoA, acetyl-CoA; 
C, citrate; IC, isocitrate; αKG, α-ketoglutarate; M, malate; MDH, malate dehydrogenase; 
OA, oxaloacetate; ME, malic enzyme, PEPCK, phosphoenolpyruvate carboxykinase; 
ACLY, ATP citrate lyase; FASN, fatty acid synthase; ELOVL, elongation of long chain 
fatty acid protein; MaCoA, Malonyl-CoA; FA, fatty acid; FACoA, fatty acyl-CoA, CPT, 
carnitinepalmitoyltransferase; AcCarnitine; acylcarnitine; ECH, enoyl CoA hydratase; GSH, 
glutathione.
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Table 1
Oligonucleotide sequences of the forward and reverse RT-PCR primers used to validate microarray results. 
Rats were sacrificed 4 h after AFB1 administration.
Gene RefSeq ID Oligonucleotide sequence
Kng1 NM_001009628 Forward Primer
Reverse Primer
5' actgcagagtccccacaaac 3'
5' cgtgtgaagcagcatcctta 3'
Abcb1a NM_133401 Forward Primer
Reverse Primer
5' tgtaatgccagggctagagg 3'
5' tgaacctggagctccctatg 3'
Nmnat3 NM_001013224 Forward Primer
Reverse Primer
5' atgcatatgggagggacatc 3'
5' agagcatttgctgctcttctg 3'
Gpt2 NM_001012057 Forward Primer
Reverse Primer
5' aggcagctcagtcccataaa 3'
5' gtaggtgccttctcgctgtc 3'
Foxa3 NM_017077 Forward Primer
Reverse Primer
5'gcctagggttggggtattgt 3'
5' attgccttcacggtatgtcc 3'
Crat NM_001004085 Forward Primer
Reverse Primer
5' gatgtgaatcatggggaagg 3'
5' acagattctggcttggctgt 3'
Gapdh NM_017008 Forward Primer
Reverse Primer
5' gtgccaaaagggtcatcat 3'
5' ccacagtcttctgagtggca 3'
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Table 2
Oligonucleotide sequences of the forward and reverse RT-PCR primers used to validate microarray results. 
Rats were sacrificed 24 h after AFB1 administration.
Gene RefSeq ID Oligonucleotide sequence
Srebf1 XM_213329 Forward Primer
Reverse Primer
5' gccaccctcttgctctgtag 3'
5' gggtgagagccttgagacag 3'
Fasn NM_017332 Forward Primer
Reverse Primer
5' agtcaccctgaaggcatcac 3'
5' caccaactgccaggtagtca 3'
Acly NM_016987 Forward Primer
Reverse Primer
5' acccttagccatcgtcacac 3'
5' gctttgcggtttccatttta 3'
Elovl6 NM_134383 Forward Primer
Reverse Primer
5' cccgtttgacctcacacata 3'
5' cagaggctgcagaaacacag 3'
Me3 XM_341880 Forward Primer
Reverse Primer
5' tggccttgtcttctccactt 3'
5' tcaagggaagtctggtcctg 3'
Pklr NM_012624 Forward Primer
Reverse Primer
5' actgctctgctgggtcagat 3'
5' ttctgggattctttgcctgt 3'
Mdh1 NM_033235 Forward Primer
Reverse Primer
5' tcatgaagccctgtgttcaa 3'
5' ggattggccatgaactcact 3'
Crat NM_001004085 Forward Primer
Reverse Primer
5' gatgtgaatcatggggaagg 3'
5' acagattctggcttggctgt 3'
Cpt1a NM_031559 Forward Primer
Reverse Primer
5' ctgactctcgctgctgtgac 3'
5' tgcattggtaactgctcagg 3'
Acf NM_133400 Forward Primer
Reverse Primer
5' ataactggggacagccagtg 3'
5' tagctttgggggtgtgaaag 3'
Gapdh NM_017008 Forward Primer
Reverse Primer
5' gtgccaaaagggtcatcat 3'
5' ccacagtcttctgagtggca 3'
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Table 3
Genes deregulated by SF in liver of AFB1-treated rats compared to the time-matched AFB1-treated controls.
Parameter 4 h group 24 h group
Probe sets 81 110
Non-redundant genes 78 97
Up-regulated 53 51
Down-regulated 25 46
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Table 5
List of SF-modulated genes in each enriched category in rats sacrificed 4 h after treatment with AFB1
RefSeq ID Gene Description Fold Change
Establishment and/or maintenance of cell polarity
XM_342223 Prkci Protein kinase C, iota 1.58
NM_012788 Dlgh1 Discs, large homolog 1 (Drosophila) 1.52
Positive regulation of development
NM_012788 Dlgh1 Discs, large homolog 1 (Drosophila) 1.52
XM_226988 Fndc3b Fibronectin type III domain containing 3B 1.77
NM_181086 Tnfrsf12a Tumor necrosis factor receptor superfamily, member 12a −2.06
Transcription, DNA-dependent
NM_022184 Cask Calcium/calmodulin-dependent serine protein kinase (MAGUK family) 1.78
NM_001014172 Rsrc1 Arginine/serine-rich coiled-coil 1 1.74
NM_012988 Nfia Nuclear factor I/A 1.62
NM_153472 Mnat1 Menage a trois 1 1.57
NM_021742 Nr5a2 Nuclear receptor subfamily 5, group A, member 2 1.54
XM_215922 Mybl2 Myeloblastosis oncogene-like 2 −1.52
NM_017077 Foxa3 Forkhead box A3 −1.53
NM_057211 Klf9 Kruppel-like factor 9 −1.61
NM_001011930 Trip13 Thyroid hormone receptor interactor 13 −1.63
XM_218336 Erf Ets2 repressor factor −1.76
NM_031800 Dedd Death effector domain-containing −1.61
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Table 6
Gene ontology showing SF enhanced gene classes in rats sacrificed 24 h after treatment with AFB1.
Gene ontology
category
Gene ontology
number
O E R P
Acetyl-CoA biosynthesis GO:0006085 2 0.04 50.00 0.0007
Iron ion homeostasis GO:0055072 2 0.12 16.67 0.0059
Fatty acid metabolism GO:0006631 5 1.05 4.76 0.0037
Lipid biosynthesis GO:0008610 5 1.21 4.13 0.0068
Cellular lipid metabolism GO:0044255 9 2.64 3.41 0.0010
Organic acid metabolism GO:0006082 9 2.77 3.25 0.0015
Carboxylic acid metabolism GO:0019752 9 2.75 3.27 0.0014
Lipid metabolism GO:0006629 10 3.21 3.12 0.0011
O:Observed gene number in the GO category; E:Expected gene number in the GO category; R:Ratio of enrichment for the GO category; 
P:Significance of enrichment for the GO category
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Table 7
List of SF-modulated genes in each enriched category in rats sacrificed 24 h after treatment with AFB1
RefSeq ID Gene Description Fold Change
Acetyl-CoA biosynthesis
NM_016987 Acly ATP citrate lyase 2.57
NM_031025 Dlat Dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) 1.78
Iron ion homeostasis
XM_340999 Trfc Transferrin receptor 2.92
NM_053469 Hamp Hepcidin antimicrobial peptide −7.47
Fatty acid / cellular lipid / organic acid / carboxylic and lipid metabolism Lipid biosynthesis
NM_017332 Fasn Fatty acid synthase 3.25
NM_012703 Thrsp Thyroid hormone responsive protein 2.90
NM_134383 Elovl6 ELOVL family member 6, elongation of long chain fatty acids 2.87
NM_016987 Acly ATP citrate lyase 2.57
XM_341880 Me Malic enzyme 3, NADP(+)-dependent, mitochondrial 1.88
XM_213329 Srebf1 Sterol regulatory element binding factor 1 1.87
NM_031025 Dlat Dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) 1.78
NM_012624 Pklr Pyruvate kinase, liver and red blood cell 1.73
NM_001007620 Pdhb Pyruvate dehydrogenase (lipoamide) beta 1.66
NM_033235 Mdh Malate dehydrogenase 1, NAD 1.59
NM_031315 Cte1 Cytosolic acyl-CoA thioesterase 1 −1.77
NM_022594 Ech1 Enoyl coenzyme A hydratase 1, peroxisomal −1.89
NM_031559 Cpt1a Carnitinepalmitoyltransferase 1a, liver −1.90
NM_138907 Mte1 Mitochondrial acyl-CoA thioesterase 1 −1.90
NM_198780 Pck1 Phosphoenolpyruvatecarboxykinase 1 −1.93
NM_001004085 Crat Carnitineacetyltransferase −2.20
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